181 related articles for article (PubMed ID: 35711823)
1. LncRNA AC098934 promotes proliferation and invasion in lung adenocarcinoma cells by combining METTL3 and m6A modifications.
Huang S; Jin M; Lan X; Wu JL; Zhang Z; Zhao J; Li Y
J Cancer; 2022; 13(8):2662-2672. PubMed ID: 35711823
[No Abstract] [Full Text] [Related]
2. METTL3 exerts synergistic effects on m6A methylation and histone modification to regulate the function of VGF in lung adenocarcinoma.
Shi K; Sa R; Dou L; Wu Y; Dong Z; Fu X; Yu H
Clin Epigenetics; 2023 Sep; 15(1):153. PubMed ID: 37742030
[TBL] [Abstract][Full Text] [Related]
3. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
[TBL] [Abstract][Full Text] [Related]
4. METTL3 Contributes to Osteosarcoma Progression by Increasing DANCR mRNA Stability
Zhou X; Yang Y; Li Y; Liang G; Kang D; Zhou B; Li Q
Front Cell Dev Biol; 2021; 9():784719. PubMed ID: 35096816
[No Abstract] [Full Text] [Related]
5. RBM15 facilities lung adenocarcinoma cell progression by regulating RASSF8 stability through N6 Methyladenosine modification.
Ma M; Wang W; Li L; Wang X; Huang Q; Zhou C; Huang Y; Zhao G; Ye L
Transl Oncol; 2024 Aug; 46():102018. PubMed ID: 38838436
[TBL] [Abstract][Full Text] [Related]
6. M2-TAMs promote immunoresistance in lung adenocarcinoma by enhancing
Wu L; Cheng D; Yang X; Zhao W; Fang C; Chen R; Ji M
Ann Transl Med; 2022 Dec; 10(24):1380. PubMed ID: 36660648
[TBL] [Abstract][Full Text] [Related]
7. c-MYC/METTL3/LINC01006 positive feedback loop promotes migration, invasion and proliferation of non-small cell lung cancer.
Liu C; Ren Q; Deng J; Wang S; Ren L
Biomed J; 2023 Sep; ():100664. PubMed ID: 37774794
[TBL] [Abstract][Full Text] [Related]
8. METTL3 promotes prostate cancer progression by regulating miR-182 maturation in m6A-dependent manner.
Wang D; Wang X; Huang B; Zhao Y; Tu W; Jin X; Shao Y; Zhu Y; Lu G
Andrologia; 2022 Aug; 54(7):1581-1591. PubMed ID: 35413135
[TBL] [Abstract][Full Text] [Related]
9.
Wu C; Dong B; Huang L; Liu Y; Ye G; Li S; Qi Y
Front Oncol; 2021; 11():754290. PubMed ID: 34745988
[TBL] [Abstract][Full Text] [Related]
10. METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2.
Meng QZ; Cong CH; Li XJ; Zhu F; Zhao X; Chen FW
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4328-4336. PubMed ID: 32373970
[TBL] [Abstract][Full Text] [Related]
11. METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m
Xu Y; Lv D; Yan C; Su H; Zhang X; Shi Y; Ying K
Cancer Cell Int; 2022 Jan; 22(1):11. PubMed ID: 34996469
[TBL] [Abstract][Full Text] [Related]
12. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
Ma Z; Li Q; Liu P; Dong W; Zuo Y
Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
[TBL] [Abstract][Full Text] [Related]
13. METTL3-mediated m
Wu Y; Chang N; Zhang Y; Zhang X; Xu L; Che Y; Qiao T; Wu B; Zhou Y; Jiang J; Xiong J; Zhang J; Zhang J
J Exp Clin Cancer Res; 2021 Mar; 40(1):90. PubMed ID: 33676554
[TBL] [Abstract][Full Text] [Related]
14. METTL3 Mediated MALAT1 m6A Modification Promotes Proliferation and Metastasis in Osteosarcoma Cells.
Zhang Y; Xu Y; Qiu G; Luo Y; Bao Y; Lu J; Wang T; Wang Y
Mol Biotechnol; 2023 Oct; ():. PubMed ID: 37897586
[TBL] [Abstract][Full Text] [Related]
15. m6A methyltransferase METTL3-induced lncRNA SNHG17 promotes lung adenocarcinoma gefitinib resistance by epigenetically repressing LATS2 expression.
Zhang H; Wang SQ; Wang L; Lin H; Zhu JB; Chen R; Li LF; Cheng YD; Duan CJ; Zhang CF
Cell Death Dis; 2022 Jul; 13(7):657. PubMed ID: 35902569
[TBL] [Abstract][Full Text] [Related]
16. N6-Methyladenosine Modification of CIRCKRT17 Initiated by METTL3 Promotes Osimertinib Resistance of Lung Adenocarcinoma by EIF4A3 to Enhance YAP1 Stability.
Ji Y; Zhao Q; Feng W; Peng Y; Hu B; Chen Q
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428672
[TBL] [Abstract][Full Text] [Related]
17. m6A Writer METTL3-Mediated lncRNA LINC01125 Prevents the Malignancy of Papillary Thyroid Cancer.
He T; Xia H; Chen B; Duan Z; Huang C
Crit Rev Immunol; 2023; 43(3):43-53. PubMed ID: 37824376
[TBL] [Abstract][Full Text] [Related]
18. KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.
Zhao W; Xie Y
Pathol Res Pract; 2021 Jan; 217():153284. PubMed ID: 33249400
[TBL] [Abstract][Full Text] [Related]
19. N6-methyladenosine-induced SVIL antisense RNA 1 restrains lung adenocarcinoma cell proliferation by destabilizing E2F1.
Hu Z; Zhu L; Zhang Y; Chen B
Bioengineered; 2022 Feb; 13(2):3093-3107. PubMed ID: 35068325
[TBL] [Abstract][Full Text] [Related]
20. METTL3 facilitates the progression of hepatocellular carcinoma by modulating the m6A level of USP7.
Li Y; Cheng X; Chen Y; Zhou T; Li D; Zheng WV
Am J Transl Res; 2021; 13(12):13423-13437. PubMed ID: 35035685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]